The Cataract Surgery Devices Market is expanding across major geographical markets due to increasing cataract prevalence, aging populations, improving healthcare infrastructure, and technological advancements. The global market is expected to grow from USD 9.52 billion in 2025 to USD 14.78 billion by 2035 at a CAGR of 4.52%.

North America currently dominates the market, accounting for approximately 35.5% of global revenue in 2025. The region benefits from advanced ophthalmic infrastructure, stable reimbursement systems, premium intraocular lens adoption, and the growing use of ambulatory surgery centers.

Europe represents another important market, supported by established healthcare systems and increasing efforts to reduce cataract surgery waiting lists. Regulatory requirements, including Medical Device Regulation compliance, are influencing manufacturers' strategies in the region.

Asia-Pacific is projected to be the fastest-growing regional market, with a forecast CAGR of 6.46%. Increasing healthcare investments, large patient populations, expanding surgical capacity, and government-supported blindness-control programs are creating significant opportunities. India and China are particularly important due to their substantial cataract surgery volumes and unmet demand.

South America and the Middle East and Africa are also expected to provide growth opportunities as healthcare access improves and governments increase investment in ophthalmic services.

Going forward, regional market performance will depend on surgical capacity expansion, technology adoption, affordability, local manufacturing, and improved access to cataract treatment.